Lisa M. Ebert

3.4k citations
59 papers · 2.8k · h-index 31

Impact in

  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
  • Oncology top 5%
    • Chemokine receptors and signaling
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • CAR-T cell therapy research 10
    • Chemokine receptors and signaling 8
    • Cancer Immunotherapy and Biomarkers 6
    • Immunotherapy and Immune Responses 12
    • T-cell and B-cell Immunology 9

Lisa M. Ebert

56 papers receiving 2.7k citations

Peers

Lisa M. Ebert
Comparison fields: 5 of 100
  • Immunology 896
  • Oncology 894
  • Genetics 299
  • Dermatology 79
  • Immunology and Allergy 47
Replace Frédérick Masson with:
Frédérick Masson Australia
Alexandre Boissonnas France
Lucia B. De Monte Italy
Jackson Nyman United States
Laura C. Bover United States
Pamela Leland United States
Andrei I. Chapoval United States
Graham P. Cook United Kingdom
Niwa Ali United Kingdom
Stephen R. Mattarollo Australia
Lisa M. Ebert relative to Frédérick Masson Australia Frédérick Masson's profile →
Citations per field
00.5×2×3×4×4.6×
Frédérick Masson · 1×
Citations per year

Countries citing papers authored by Lisa M. Ebert

Since Specialization
Citations

This map shows the geographic impact of Lisa M. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Ebert more than expected).

Fields of papers citing papers by Lisa M. Ebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Ebert. The network helps show where Lisa M. Ebert may publish in the future.

Co-authors

The 25 scholars most cited alongside Lisa M. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisa M. Ebert Line = papers co-authored together Lisa M. Ebert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004237
2 2006207
3 2004181
4 2008157
5 2005127
6 2019125
7 2009108
8 1999106
9 200694
10 200988
11 202287
12 200272
13 202170
14 201563
15 201257
16 202055
17 201253
18 202049
19 201645
20 200944

About Lisa M. Ebert

Lisa M. Ebert is a scholar working on Oncology, Immunology, Genetics, Molecular Biology and Hematology, having authored 59 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Glioma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (10 papers), T-cell and B-cell Immunology (9 papers), Chemokine receptors and signaling (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (896 citations), Oncology (894 citations), Genetics (299 citations), Dermatology (79 citations) and Immunology and Allergy (47 citations). Lisa M. Ebert has collaborated with scholars based in Australia, Switzerland and United States. Frequent co-authors include Bernhard Moser, Patrick Schaerli, Shaun R. McColl, Michael Paul Brown, Simone Meuter, Tessa Gargett, Weisan Chen, Jonathan Simon Cebon, Ian D. Davis and Katharina Willimann. Their work appears in journals such as Clinical & Translational Immunology, The Journal of Immunology, Oncotarget, Journal for ImmunoTherapy of Cancer and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact